Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2019 2
2020 4
2021 6
2022 1
Text availability
Article attribute
Article type
Publication date

Search Results

12 results
Results by year
Filters applied: . Clear all
Page 1
Genetics, diagnosis, management and future directions of research of phaeochromocytoma and paraganglioma: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension.
Lenders JWM, Kerstens MN, Amar L, Prejbisz A, Robledo M, Taieb D, Pacak K, Crona J, Zelinka T, Mannelli M, Deutschbein T, Timmers HJLM, Castinetti F, Dralle H, Widimský J, Gimenez-Roqueplo AP, Eisenhofer G. Lenders JWM, et al. J Hypertens. 2020 Aug;38(8):1443-1456. doi: 10.1097/HJH.0000000000002438. J Hypertens. 2020. PMID: 32412940 Free PMC article. Review.
Pheochromocytoma (PHEO) and Paraganglioma (PGL).
Pacak K, Taïeb D. Pacak K, et al. Cancers (Basel). 2019 Sep 18;11(9):1391. doi: 10.3390/cancers11091391. Cancers (Basel). 2019. PMID: 31540433 Free PMC article.
Mannan-BAM, TLR ligands, and anti-CD40 immunotherapy in established murine pancreatic adenocarcinoma: understanding therapeutic potentials and limitations.
Uher O, Caisova V, Padoukova L, Kvardova K, Masakova K, Lencova R, Frejlachova A, Skalickova M, Venhauerova A, Chlastakova A, Hansen P, Chmelar J, Kopecky J, Zhuang Z, Pacak K, Zenka J. Uher O, et al. Cancer Immunol Immunother. 2021 Nov;70(11):3303-3312. doi: 10.1007/s00262-021-02920-9. Epub 2021 Apr 15. Cancer Immunol Immunother. 2021. PMID: 33855601
12 results